The first cardiac bioimplant developed to treat patients with myocardial infarction, the PeriCord
When a myocardial infarction occurs, blood stops circulating and properly nourishing the heart muscle cells. The heart loses strength to beat due to the death of cells in the injured area, which have stopped receiving blood from the coronary arteries. As a result of cell death, a permanent non-contractile scar is generated, which affects the […]
iCor – IGTP and Boehringer Ingelheim strengthen their collaboration with preclinical research
The biopharmaceutical company Boehringer Ingelheim has signed a new collaboration agreement with the Germans Trias i Pujol Research Institute (IGTP) to launch a new research project focused on evaluating the potential benefit of a new molecule in the cardiovascular-renal-metabolic axis. The alliance between both institutions is part of a strategic collaboration initiated in 2020 between […]
The Heart Area of Germans Trias, the first health center in the State to participate with a patient in the international EASY-AS study
The Heart Institute of the Germans Trias i Pujol University Hospital (iCor) has been the first hospital in Spain to include a patient in the international EASY-AS study (Asymptomatic Aortic Estenosis). The main objective of this clinical trial is to establish an early aortic valve replacement strategy in asymptomatic patients with severe aortic stenosis that […]
The first VASCRAFT bioimplant successfully applied
The consortium made up of the Blood and Tissue Bank (BST), the Germans Trias i Pujol Research Institute (IGTP) and IQS Barcelona has successfully performed the first vascular graft of biological origin, known as VASCRAFT, as a therapeutic and innovative alternative for coronary bypass in patients with coronary disease. The VASCRAFT project, formed by a […]
